Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors
- 22 August 1998
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (19) , 3568-3571
- https://doi.org/10.1021/jm980253r
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Design and synthesis of the cartilage protective agent (CPA, Ro32-3555)Bioorganic & Medicinal Chemistry Letters, 1997
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in RabbitsJournal of Medicinal Chemistry, 1997
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992
- Gene Expression (Collagenase, Tissue Inhibitor of Metalloproteinases, Complement, and HLA–DR) in Rheumatoid Arthritis and Osteoarthritis Synovium. Quantitative Analysis and Effect of Intraarticular CorticosteroidsArthritis & Rheumatism, 1991
- Demonstration of tissue collagenase activity in vivo and its relationship to inflammation severity in human gingivaJournal of Periodontal Research, 1987